A new clinical study has demonstrated that medicinal cannabis shows beneficial results in treating the grave symptoms of Tourette Syndrome, reported The…
Avecho Biotechnology (ASX: AVE) is poised to begin “pivotal” phase III clinical studies evaluating its proprietary cannabidiol (CBD) soft gel capsule in treating insomnia.